Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

Clinical trial NCT06631040 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06631040
Sponsor: Shahid Beheshti University of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia in Relapse

Start date: 2024-12-19
Primary completion: 2026-11-20
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.